Jane L. Delgado

Jane L. Delgado discloses dealings in Adams Respiratory Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 19 April 2007 to 29 January 2008, the count stands at 5 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Most recently, on 30 January 2008, the filings show a transaction worth €44k in Adams Respiratory Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.